ABCB1 and breast carcinoma: Berbamine has, on the other hand, been shown to down-regulate the expression of MDR1 mRNA after 72 h treatment in human erythroleukemic cells [35] as well as modulating multi-drug resistance (MDR) in breast cancer cells [36].